Objective: Programmed cell death-ligand 1 (PD-L1) expression and immune phenotype (IP) are potential predictive biomarkers for immune checkpoint inhibitors (ICIs) in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC). This study evaluated the predictive value of combining PD-L1 expression and IP in R/M HNSCC.
Study design: Forty-one R/M HNSCC patients treated with ICI were included. PD-L1 expression was evaluated using the standardized 22C3 pharmDx assay. IPs were assessed using Lunit SCOPE IO, an artificial intelligence-powered tumor-infiltrating lymphocyte analyzer.
Results: Thirty-nine patients (95.1%) were classified as PD-L1 positive (combined positive score ≥1). Overall, 27 (65.9%) had desert IP. PD-L1 expression and IP were combined to classify patients into 3 groups: group A, negative PD-L1; group B, positive PD-L1 with desert IP; group C, positive PD-L1 with non-desert IP. The median progression-free survival (PFS) was 1.2 months in group A, 2.1 months in group B, and 12.1 months in group C (P = .015). In multivariate Cox analysis, PD-L1 expression combined with IP was an independent factor for PFS, with a hazard ratio of 0.14 (P = .018) in group C and 0.37 (P = .186) in group B, relative to group A.
Conclusions: In R/M HNSCC, integrating IP with PD-L1 expression may enhance prediction of ICI outcomes.
{"title":"PD-L1 expression combined with immune phenotype is a potential predictor of outcome with PD-1 inhibitor monotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.","authors":"Dong Hyun Kim, Jiwon Koh, Jong Seok Ahn, Jimin Moon, Mingu Kang, Gahee Park, Yoojoo Lim, Chan-Young Ock, Yoon Kyung Jeon, Kyeong Cheon Jung, Soon-Hyun Ahn, Eun-Jae Chung, Seong-Keun Kwon, Bhumsuk Keam","doi":"10.1016/j.oooo.2025.11.018","DOIUrl":"10.1016/j.oooo.2025.11.018","url":null,"abstract":"<p><strong>Objective: </strong>Programmed cell death-ligand 1 (PD-L1) expression and immune phenotype (IP) are potential predictive biomarkers for immune checkpoint inhibitors (ICIs) in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC). This study evaluated the predictive value of combining PD-L1 expression and IP in R/M HNSCC.</p><p><strong>Study design: </strong>Forty-one R/M HNSCC patients treated with ICI were included. PD-L1 expression was evaluated using the standardized 22C3 pharmDx assay. IPs were assessed using Lunit SCOPE IO, an artificial intelligence-powered tumor-infiltrating lymphocyte analyzer.</p><p><strong>Results: </strong>Thirty-nine patients (95.1%) were classified as PD-L1 positive (combined positive score ≥1). Overall, 27 (65.9%) had desert IP. PD-L1 expression and IP were combined to classify patients into 3 groups: group A, negative PD-L1; group B, positive PD-L1 with desert IP; group C, positive PD-L1 with non-desert IP. The median progression-free survival (PFS) was 1.2 months in group A, 2.1 months in group B, and 12.1 months in group C (P = .015). In multivariate Cox analysis, PD-L1 expression combined with IP was an independent factor for PFS, with a hazard ratio of 0.14 (P = .018) in group C and 0.37 (P = .186) in group B, relative to group A.</p><p><strong>Conclusions: </strong>In R/M HNSCC, integrating IP with PD-L1 expression may enhance prediction of ICI outcomes.</p>","PeriodicalId":49010,"journal":{"name":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","volume":" ","pages":"679-689"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145900459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To investigate the association between self-reported race and ethnicity with oral potentially malignant disorders and oral cancer, considering environmental and genetic influences.
Study design: This was a case-control study including clinical information and DNA samples from 792 subjects from the University of Pittsburgh dental clinics. The cases were 264 subjects diagnosed with oral potential malignant disorders or oral squamous cell carcinoma. Controls were matched by sex and age in a 1:2 ratio. χ2 tests detected differences between groups regarding ethnicity, race, and covariates. A Post-hoc test with Bonferroni and Holm corrections accounted for multiple comparisons between groups. A standard χ2 residual test was used to investigate which ethnicity category contributed most to the association. Multiple logistic regression models were used to obtain the unadjusted and adjusted odds ratios (ORs) and to detect the association between single-nucleotide variants and outcomes, stratified by ethnicity and race.
Results: The risk of having the outcomes was 78% greater in those patients who self-reported as African American (OR, 1.78; P = .002; 95% confidence interval, 1.225-2.592). Minor allele G (rs9879992-GSK3B) increased the risk for the outcomes in patients who self-reported as African American (OR, 1.85; P = .002; 95% confidence interval, 1.236-2.772).
Conclusions: Self-reported race and ethnicity were associated with oral potential malignant disorder/oral cancer. Future studies using ancestry informative markers can confirm these findings.
目的:在考虑环境和遗传影响的情况下,探讨自我报告的种族和民族与口腔潜在恶性疾病和口腔癌的关系。研究设计:这是一项病例对照研究,包括来自匹兹堡大学牙科诊所的792名受试者的临床信息和DNA样本。264例被诊断为口腔潜在恶性疾病或口腔鳞状细胞癌的患者。对照组按性别和年龄按1:2的比例配对。χ2检验检测各组在民族、种族和协变量方面的差异。采用Bonferroni和Holm校正的事后检验解释了组间的多重比较。采用标准χ2残差检验来调查哪个种族类别对相关性贡献最大。采用多元逻辑回归模型获得未调整和调整后的优势比(or),并检测单核苷酸变异与结果之间的关联,并按种族和种族分层。结果:自我报告为非裔美国人的患者出现上述结果的风险高出78% (OR, 1.78; P = 0.002; 95%可信区间,1.225-2.592)。小等位基因G (rs9879992-GSK3B)增加了自我报告为非洲裔美国人的预后风险(OR, 1.85; P = 0.002; 95%可信区间,1.236-2.772)。结论:自我报告的种族和民族与口腔潜在恶性疾病/口腔癌相关。未来使用祖先信息标记的研究可以证实这些发现。
{"title":"Self-reported race and ethnicity in relation to oral potentially malignant disorders and oral cancer.","authors":"Adriana Mendonca da Silva, Polyanna Oliveira, Mariana Bezamat Chappel, Alexandre Rezende Vieira","doi":"10.1016/j.oooo.2025.11.006","DOIUrl":"10.1016/j.oooo.2025.11.006","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the association between self-reported race and ethnicity with oral potentially malignant disorders and oral cancer, considering environmental and genetic influences.</p><p><strong>Study design: </strong>This was a case-control study including clinical information and DNA samples from 792 subjects from the University of Pittsburgh dental clinics. The cases were 264 subjects diagnosed with oral potential malignant disorders or oral squamous cell carcinoma. Controls were matched by sex and age in a 1:2 ratio. χ<sup>2</sup> tests detected differences between groups regarding ethnicity, race, and covariates. A Post-hoc test with Bonferroni and Holm corrections accounted for multiple comparisons between groups. A standard χ<sup>2</sup> residual test was used to investigate which ethnicity category contributed most to the association. Multiple logistic regression models were used to obtain the unadjusted and adjusted odds ratios (ORs) and to detect the association between single-nucleotide variants and outcomes, stratified by ethnicity and race.</p><p><strong>Results: </strong>The risk of having the outcomes was 78% greater in those patients who self-reported as African American (OR, 1.78; P = .002; 95% confidence interval, 1.225-2.592). Minor allele G (rs9879992-GSK3B) increased the risk for the outcomes in patients who self-reported as African American (OR, 1.85; P = .002; 95% confidence interval, 1.236-2.772).</p><p><strong>Conclusions: </strong>Self-reported race and ethnicity were associated with oral potential malignant disorder/oral cancer. Future studies using ancestry informative markers can confirm these findings.</p>","PeriodicalId":49010,"journal":{"name":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","volume":" ","pages":"610-617"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145821810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-05-01Epub Date: 2025-10-30DOI: 10.1016/j.oooo.2025.10.016
Jackson Lech, Eduard Popa, Brian Kinard
Objective: This case series evaluates the impact of well-controlled human immunodeficiency virus (HIV) on the success of elective orthognathic osteotomies.
Methods: A retrospective review of HIV-positive patients undergoing elective orthognathic osteotomies was conducted. Inclusion criteria required patients to have an HIV diagnosis, undergo orthognathic surgery, and be treated with ART, leading to well-controlled HIV (viral load below 200 copies/mL). Those with incomplete records were excluded. Study variables were grouped into demographic (e.g., age, sex, dentofacial deformity), HIV-specific (e.g., viral load, CD4 count), and operative (e.g., procedure type). Perioperative management included continued antiretroviral therapy (ART), antibiotic prophylaxis, and strict infection control.
Results: Three patients (aged 34-59) with well-controlled HIV underwent Le Fort osteotomy and bilateral sagittal split osteotomy (BSSO). Two had developmental dentofacial deformities, one was post-traumatic. Two Le Forts were 2-piece, one was 3-piece; 2 patients had BSSO. All showed successful bone healing without increased infection or nonunion rates post-allogenic bone grafts.
Conclusion: Well-managed HIV-positive patients can achieve successful outcomes in elective orthognathic osteotomies, comparable to those in HIV-negative individuals. The small sample limits generalizability, warranting further research to assess long-term outcomes and refine perioperative guidelines.
{"title":"Do HIV-positive patients achieve successful outcomes in elective orthognathic osteotomies?: A case series.","authors":"Jackson Lech, Eduard Popa, Brian Kinard","doi":"10.1016/j.oooo.2025.10.016","DOIUrl":"10.1016/j.oooo.2025.10.016","url":null,"abstract":"<p><strong>Objective: </strong>This case series evaluates the impact of well-controlled human immunodeficiency virus (HIV) on the success of elective orthognathic osteotomies.</p><p><strong>Methods: </strong>A retrospective review of HIV-positive patients undergoing elective orthognathic osteotomies was conducted. Inclusion criteria required patients to have an HIV diagnosis, undergo orthognathic surgery, and be treated with ART, leading to well-controlled HIV (viral load below 200 copies/mL). Those with incomplete records were excluded. Study variables were grouped into demographic (e.g., age, sex, dentofacial deformity), HIV-specific (e.g., viral load, CD4 count), and operative (e.g., procedure type). Perioperative management included continued antiretroviral therapy (ART), antibiotic prophylaxis, and strict infection control.</p><p><strong>Results: </strong>Three patients (aged 34-59) with well-controlled HIV underwent Le Fort osteotomy and bilateral sagittal split osteotomy (BSSO). Two had developmental dentofacial deformities, one was post-traumatic. Two Le Forts were 2-piece, one was 3-piece; 2 patients had BSSO. All showed successful bone healing without increased infection or nonunion rates post-allogenic bone grafts.</p><p><strong>Conclusion: </strong>Well-managed HIV-positive patients can achieve successful outcomes in elective orthognathic osteotomies, comparable to those in HIV-negative individuals. The small sample limits generalizability, warranting further research to assess long-term outcomes and refine perioperative guidelines.</p>","PeriodicalId":49010,"journal":{"name":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","volume":" ","pages":"593-597"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145641751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-05-01Epub Date: 2026-01-21DOI: 10.1016/j.oooo.2025.11.022
Ana Lia Anbinder, Bruno Augusto Benevenuto de Andrade, Thayná Isabele Stopiello Costa, Juliana Dos Santos Lupp, Luis Augusto de Almeida-Silva, Michelle Bianchi de Moraes
{"title":"Could idiopathic gingival papillokeratosis represent an exaggerated form of gingival stippling?","authors":"Ana Lia Anbinder, Bruno Augusto Benevenuto de Andrade, Thayná Isabele Stopiello Costa, Juliana Dos Santos Lupp, Luis Augusto de Almeida-Silva, Michelle Bianchi de Moraes","doi":"10.1016/j.oooo.2025.11.022","DOIUrl":"10.1016/j.oooo.2025.11.022","url":null,"abstract":"","PeriodicalId":49010,"journal":{"name":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","volume":" ","pages":"730-732"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146198038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: This study aimed to identify whether immunonutritional biomarkers as prognostic factors are related to the prognosis of the conservative management of medication-related osteonecrosis of the jaw (MRONJ).
Study design: This retrospective observational study investigated the prognostic factors, including the immunonutritional biomarkers, that are associated with the conservative treatment outcomes of patients with MRONJ enrolled from 2010 to 2023.
Results: A total of 77 lesions were included, of which 38 (49%) showed complete healing of the MRONJ. On the multivariate logistic regression analysis, hemoglobin (>11.8 g/dL; odds ratio [OR] = 6.77; 95% confidence interval [CI], 1.95-23.50, P = .003), albumin (>4.0 g/dL; OR = 8.43; 95% CI, 2.12-33.60; P = .003), prognostic nutritional index (PNI; >46.6; OR = 6.53; 95% CI, 1.18-23.50; P = .004), and the hemoglobin, albumin, lymphocyte, and platelet (HALP) score (>20.46; OR = 4.77; 95% CI, 1.48-15.40; P = .009) were significantly associated with complete healing of MRONJ.
Conclusion: The results indicate that immunonutritional biomarkers such as albumin, hemoglobin, PNI, and HALP scores obtained from the laboratory data in daily clinical practice were found to be significantly associated with treatment outcomes of MRONJ.
目的:本研究旨在确定作为预后因素的免疫营养生物标志物是否与药物相关性颌骨骨坏死(MRONJ)保守治疗的预后有关。研究设计:本回顾性观察性研究调查了与2010 - 2023年MRONJ患者保守治疗结果相关的预后因素,包括免疫营养生物标志物。结果:共纳入77例病变,其中38例(49%)MRONJ完全愈合。在多因素logistic回归分析中,血红蛋白(>11.8 g/dL,比值比[OR] = 6.77, 95%可信区间[CI], 1.95 ~ 23.50, P = 0.003)、白蛋白(>4.0 g/dL, OR = 8.43, 95% CI, 2.12 ~ 33.60, P = 0.003)、预后营养指数(PNI, >46.6, OR = 6.53, 95% CI, 1.18 ~ 23.50, P = 0.004)、血红蛋白、白蛋白、淋巴细胞和血小板(HALP)评分(>20.46,OR = 4.77, 95% CI, 1.48 ~ 15.40, P = 0.009)与MRONJ完全愈合显著相关。结论:结果表明,在日常临床实践中,从实验室数据中获得的免疫营养生物标志物如白蛋白、血红蛋白、PNI和HALP评分与MRONJ的治疗结果显著相关。
{"title":"Prognosis of medication-related osteonecrosis of the jaw based on the immunonutritional biomarker.","authors":"Takahito Aoki, Takazumi Yasui, Kenta Tanaka, Hiroki Nagamine, Moemi Kimura, Hidetaka Miyashita, Ryotaro Iwasaki, Seiji Asoda, Katsuhiro Onizawa","doi":"10.1016/j.oooo.2026.01.005","DOIUrl":"10.1016/j.oooo.2026.01.005","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to identify whether immunonutritional biomarkers as prognostic factors are related to the prognosis of the conservative management of medication-related osteonecrosis of the jaw (MRONJ).</p><p><strong>Study design: </strong>This retrospective observational study investigated the prognostic factors, including the immunonutritional biomarkers, that are associated with the conservative treatment outcomes of patients with MRONJ enrolled from 2010 to 2023.</p><p><strong>Results: </strong>A total of 77 lesions were included, of which 38 (49%) showed complete healing of the MRONJ. On the multivariate logistic regression analysis, hemoglobin (>11.8 g/dL; odds ratio [OR] = 6.77; 95% confidence interval [CI], 1.95-23.50, P = .003), albumin (>4.0 g/dL; OR = 8.43; 95% CI, 2.12-33.60; P = .003), prognostic nutritional index (PNI; >46.6; OR = 6.53; 95% CI, 1.18-23.50; P = .004), and the hemoglobin, albumin, lymphocyte, and platelet (HALP) score (>20.46; OR = 4.77; 95% CI, 1.48-15.40; P = .009) were significantly associated with complete healing of MRONJ.</p><p><strong>Conclusion: </strong>The results indicate that immunonutritional biomarkers such as albumin, hemoglobin, PNI, and HALP scores obtained from the laboratory data in daily clinical practice were found to be significantly associated with treatment outcomes of MRONJ.</p>","PeriodicalId":49010,"journal":{"name":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","volume":" ","pages":"632-639"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146167684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-05-01Epub Date: 2026-01-31DOI: 10.1016/j.oooo.2025.11.019
Jay Saepoo, Nidhi Handoo, Sherry Timmons, Emily Lanzel, Kittiphoj Tikkhanarak, John William Hellstein
{"title":"Corrigendum to 'Cocamidopropyl betaine: another possible oral healthcare chemical associated with plasma cell lesions of the oral cavity'[Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology Volume 140, Issue 2, (2025), Pages 218-226].","authors":"Jay Saepoo, Nidhi Handoo, Sherry Timmons, Emily Lanzel, Kittiphoj Tikkhanarak, John William Hellstein","doi":"10.1016/j.oooo.2025.11.019","DOIUrl":"10.1016/j.oooo.2025.11.019","url":null,"abstract":"","PeriodicalId":49010,"journal":{"name":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","volume":" ","pages":"733"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146100596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-05-01Epub Date: 2025-12-29DOI: 10.1016/j.oooo.2025.12.013
Lisanne V van Dijk, Juan Ventura, Kareem A Wahid, Lin L Zhu, Brigid A McDonald, Sara Ahmed, Keith L Sanders, Sonja M Stieb, Lance McCoy, Christina S Sharafi, Kathryn E Preston, Natalie A West, Sarah Mirbahaeddin, Dina M El-Habashy, Travis Salzillo, Samuel Mulder, Joly Fahim, Aubryane DeArmas, Mona Arbab, Yao Ding, Jihong Wang, Bastien Rigaud, Anando Sen, Mark Chambers, Katherine A Hutcheson, Kristy K Brock, Abdallah S R Mohamed, Stephen Y Lai, Clifton D Fuller
Objectives: Determine the utility of low-flip angle "black bone" magnetic resonance imaging (MRI) for cortical mandibular bone assessment compared to computed tomography (CT).
Methods: Quantification of cortical mandibular bone width was performed per Hamada et al. at 15 cross-sectional interdentium locations on pretreatment black bone MRI and CT for 15 oropharyngeal cancer patients, with interobserver analyses on a subset of three patients by 11 observers. CT and MRI measurements were compared using Bland-Altman analysis, Lin's concordance, and Deming regression; interobserver variability was assessed with absolute variance and intraclass correlation coefficient (ICC).
Results: Bland Altman and Deming regression analyses showed CT and black bone MRI measurements were comparable within ±0.85mm limits of agreement, and systematically smaller for MRI. ICC (0.60[0.52;0.67]) showed moderate equivalence between modalities. The average absolute variance between the observers was similar on CT (1.13±0.06mm) and MRI (1.15±0.06mm). ICC analysis showed that measurement consistency was significantly higher (p<0.001) for black bone MRI (0.43[0.32;0.56]) than CT (0.22[0.13;0.35]); nonetheless, ICC was poor for both modalities.
Conclusion: Black bone MRI is a viable alternative to CT for assessing mandibular cortical bone and early detection of anatomical changes like osteoradionecrosis. Both modalities showed similar interobserver variability, which may be reduced through (semi)automated measurement.
{"title":"Black bone MRI morphometry for mandibular cortical bone measurement in head and neck cancer patients: prospective method comparison with CT.","authors":"Lisanne V van Dijk, Juan Ventura, Kareem A Wahid, Lin L Zhu, Brigid A McDonald, Sara Ahmed, Keith L Sanders, Sonja M Stieb, Lance McCoy, Christina S Sharafi, Kathryn E Preston, Natalie A West, Sarah Mirbahaeddin, Dina M El-Habashy, Travis Salzillo, Samuel Mulder, Joly Fahim, Aubryane DeArmas, Mona Arbab, Yao Ding, Jihong Wang, Bastien Rigaud, Anando Sen, Mark Chambers, Katherine A Hutcheson, Kristy K Brock, Abdallah S R Mohamed, Stephen Y Lai, Clifton D Fuller","doi":"10.1016/j.oooo.2025.12.013","DOIUrl":"10.1016/j.oooo.2025.12.013","url":null,"abstract":"<p><strong>Objectives: </strong>Determine the utility of low-flip angle \"black bone\" magnetic resonance imaging (MRI) for cortical mandibular bone assessment compared to computed tomography (CT).</p><p><strong>Methods: </strong>Quantification of cortical mandibular bone width was performed per Hamada et al. at 15 cross-sectional interdentium locations on pretreatment black bone MRI and CT for 15 oropharyngeal cancer patients, with interobserver analyses on a subset of three patients by 11 observers. CT and MRI measurements were compared using Bland-Altman analysis, Lin's concordance, and Deming regression; interobserver variability was assessed with absolute variance and intraclass correlation coefficient (ICC).</p><p><strong>Results: </strong>Bland Altman and Deming regression analyses showed CT and black bone MRI measurements were comparable within ±0.85mm limits of agreement, and systematically smaller for MRI. ICC (0.60[0.52;0.67]) showed moderate equivalence between modalities. The average absolute variance between the observers was similar on CT (1.13±0.06mm) and MRI (1.15±0.06mm). ICC analysis showed that measurement consistency was significantly higher (p<0.001) for black bone MRI (0.43[0.32;0.56]) than CT (0.22[0.13;0.35]); nonetheless, ICC was poor for both modalities.</p><p><strong>Conclusion: </strong>Black bone MRI is a viable alternative to CT for assessing mandibular cortical bone and early detection of anatomical changes like osteoradionecrosis. Both modalities showed similar interobserver variability, which may be reduced through (semi)automated measurement.</p>","PeriodicalId":49010,"journal":{"name":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","volume":" ","pages":"690-700"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12962360/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146214638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-05-01Epub Date: 2025-10-29DOI: 10.1016/j.oooo.2025.10.011
Merve Demirel, Alper Aktas, Mevlüde Kizil, Nadir Yalcin
Objective: This randomized, double-blind, split-mouth clinical trial evaluated the effects of oral vitamin C supplementation on early wound healing and postoperative complications following the surgical extraction of impacted mandibular third molars.
Study design: Fifty-six healthy individuals underwent bilateral extractions, with vitamin C and placebo randomly assigned to each side. Supplementation began 1 day before surgery and continued for 7 days. Clinical outcomes, including pain, analgesic consumption, wound healing, facial swelling, and trismus, were measured preoperatively and on postoperative days 2 and 7.
Results: Pain scores were significantly lower in the vitamin C group on day 2, while analgesic use and wound healing showed favorable trends, although these differences did not reach statistical significance. Facial swelling was significantly reduced on day 2 in the vitamin C group across all measurements. Trismus did not differ significantly between groups.
Conclusions: Oral vitamin C supplementation may reduce early postoperative pain and swelling and may support early wound healing following third molar surgery. As a safe, accessible, and low-cost intervention, vitamin C could serve as a useful adjunct in oral surgical practice to improve patient recovery and comfort. Further randomized controlled trials with longer follow-up and optimized dosing protocols are warranted.
{"title":"Vitamin C and postoperative outcomes following mandibular third molar extraction: a randomized split-mouth study.","authors":"Merve Demirel, Alper Aktas, Mevlüde Kizil, Nadir Yalcin","doi":"10.1016/j.oooo.2025.10.011","DOIUrl":"10.1016/j.oooo.2025.10.011","url":null,"abstract":"<p><strong>Objective: </strong>This randomized, double-blind, split-mouth clinical trial evaluated the effects of oral vitamin C supplementation on early wound healing and postoperative complications following the surgical extraction of impacted mandibular third molars.</p><p><strong>Study design: </strong>Fifty-six healthy individuals underwent bilateral extractions, with vitamin C and placebo randomly assigned to each side. Supplementation began 1 day before surgery and continued for 7 days. Clinical outcomes, including pain, analgesic consumption, wound healing, facial swelling, and trismus, were measured preoperatively and on postoperative days 2 and 7.</p><p><strong>Results: </strong>Pain scores were significantly lower in the vitamin C group on day 2, while analgesic use and wound healing showed favorable trends, although these differences did not reach statistical significance. Facial swelling was significantly reduced on day 2 in the vitamin C group across all measurements. Trismus did not differ significantly between groups.</p><p><strong>Conclusions: </strong>Oral vitamin C supplementation may reduce early postoperative pain and swelling and may support early wound healing following third molar surgery. As a safe, accessible, and low-cost intervention, vitamin C could serve as a useful adjunct in oral surgical practice to improve patient recovery and comfort. Further randomized controlled trials with longer follow-up and optimized dosing protocols are warranted.</p>","PeriodicalId":49010,"journal":{"name":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","volume":" ","pages":"575-582"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145641703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-05-01Epub Date: 2026-01-31DOI: 10.1016/j.oooo.2025.11.020
Gavin Soppe, Jay Saepoo, Emily Lanzel, Sherry Timmons, Nidhi Handoo, John Hellstein, Amy Greenwood
{"title":"Corrigendum to 'What's in your toothpaste? A review of toothpaste ingredients and rationale for their use or avoidance' [Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology Volume 140, Issue 6, (2025), Pages 807-812].","authors":"Gavin Soppe, Jay Saepoo, Emily Lanzel, Sherry Timmons, Nidhi Handoo, John Hellstein, Amy Greenwood","doi":"10.1016/j.oooo.2025.11.020","DOIUrl":"10.1016/j.oooo.2025.11.020","url":null,"abstract":"","PeriodicalId":49010,"journal":{"name":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","volume":" ","pages":"734"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146100631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-05-01Epub Date: 2025-10-31DOI: 10.1016/j.oooo.2025.10.012
Giulio Cirignaco, Pamela Rosettani, Lisa Catarzi, Mariagrazia Paglianiti, Enrico Betti, Umberto Committeri, Luigi Angelo Vaira, Andrea Santarelli, Giuseppe Consorti
Objective: Surgical site infections (SSI) are a common but clinically significant postoperative complication in oral squamous cell carcinoma (OSCC) surgery with center-specific microbiology. This study aimed to quantify SSI incidence, identify independent predictors as a pre-ERAS baseline, with an exploratory estimate of ERAS impact.
Study design: Retrospective cohort at a major Italian center, including 575 adults undergoing OSCC resection. SSI were defined per Centers for Disease Control and Prevention (CDC/NHSN) criteria with a 30-day surveillance window. Cultures/susceptibility testing were obtained when infection was suspected. Multivariable logistic regression with Lasso and Cox models estimated odds and hazard ratios; receiver operating characteristic analyses assessed discrimination.
Results: SSI occurred in 24.3% patients with a median onset 7 days. Independent predictors were age per 10 years, smoking, alcohol use, and radical neck dissection (RND) as supported by Cox estimates. Exploratorily, the ERAS period (late-2022 onward) was associated with lower SSI hazard. Microbiology was predominantly polymicrobial (71.4%), led by Staphylococcus aureus and Pseudomonas aeruginosa.
Conclusion: s: Age, smoking, alcohol use, and RND predict SSI. ERAS pathway was introduced in 2022. Future prospective studies are needed to improve outcomes, considering that microbiological findings and resistance rates reflect the local ecology of a tertiary Italian center and may differ in other settings.
{"title":"Surgical site infections in oral cavity carcinoma: predictive factors, microbiological trends, and clinical implications-experience of a major Italian medical center.","authors":"Giulio Cirignaco, Pamela Rosettani, Lisa Catarzi, Mariagrazia Paglianiti, Enrico Betti, Umberto Committeri, Luigi Angelo Vaira, Andrea Santarelli, Giuseppe Consorti","doi":"10.1016/j.oooo.2025.10.012","DOIUrl":"10.1016/j.oooo.2025.10.012","url":null,"abstract":"<p><strong>Objective: </strong>Surgical site infections (SSI) are a common but clinically significant postoperative complication in oral squamous cell carcinoma (OSCC) surgery with center-specific microbiology. This study aimed to quantify SSI incidence, identify independent predictors as a pre-ERAS baseline, with an exploratory estimate of ERAS impact.</p><p><strong>Study design: </strong>Retrospective cohort at a major Italian center, including 575 adults undergoing OSCC resection. SSI were defined per Centers for Disease Control and Prevention (CDC/NHSN) criteria with a 30-day surveillance window. Cultures/susceptibility testing were obtained when infection was suspected. Multivariable logistic regression with Lasso and Cox models estimated odds and hazard ratios; receiver operating characteristic analyses assessed discrimination.</p><p><strong>Results: </strong>SSI occurred in 24.3% patients with a median onset 7 days. Independent predictors were age per 10 years, smoking, alcohol use, and radical neck dissection (RND) as supported by Cox estimates. Exploratorily, the ERAS period (late-2022 onward) was associated with lower SSI hazard. Microbiology was predominantly polymicrobial (71.4%), led by Staphylococcus aureus and Pseudomonas aeruginosa.</p><p><strong>Conclusion: </strong>s: Age, smoking, alcohol use, and RND predict SSI. ERAS pathway was introduced in 2022. Future prospective studies are needed to improve outcomes, considering that microbiological findings and resistance rates reflect the local ecology of a tertiary Italian center and may differ in other settings.</p>","PeriodicalId":49010,"journal":{"name":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","volume":" ","pages":"583-592"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145598031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}